Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$769M |
| 2 |
Meta Platforms (Facebook)
META
|
+$382M |
| 3 |
Roblox
RBLX
|
+$329M |
| 4 |
Tesla
TSLA
|
+$287M |
| 5 |
Qualcomm
QCOM
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$407M |
| 2 |
Visa
V
|
+$345M |
| 3 |
Snowflake
SNOW
|
+$344M |
| 4 |
Micron Technology
MU
|
+$278M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.91% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 9.99% |
| 5 | Communication Services | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
2476
Axon Enterprise
AXON
$49.1B
| $1M | ﹤0.01% |
5,723
-12,210
| -68% | -$2.22M |
|
2477
Cerus
CERS
$457M
| $1M | ﹤0.01% |
164,484
-3,111
| -2% | -$18.1K |
|
2478
BioXcel Therapeutics
BTAI
$26M
| $999K | ﹤0.01% |
2,056
+542
| +36% | +$238K |
|
2479
Genesis Energy
GEL
$1.82B
| $997K | ﹤0.01% |
100,000
-24,128
| -19% | -$222K |
|
2480
OptimizeRx
OPRX
$130M
| $996K | ﹤0.01% |
11,647
-77
| -0.7% | -$4.83K |
|
2481
Stewart Information Services
STC
$2.07B
| $996K | ﹤0.01% |
15,740
-2,540
| -14% | -$151K |
|
2482
PAR Technology
PAR
$727M
| $995K | ﹤0.01% |
16,188
-6,862
| -30% | -$440K |
|
2483
Fortuna Silver Mines
FSM
$2.91B
| $993K | ﹤0.01% |
252,382
-33,211
| -12% | -$149K |
|
|
YTPG
2484
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $993K | ﹤0.01% |
101,423
-47,078
| -32% | -$464K |
|
|
SCVX
2485
DELISTED
SCVX Corp.
SCVX
| $993K | ﹤0.01% |
100,000
| – | – |
|
2486
StoneX
SNEX
$9.2B
| $988K | ﹤0.01% |
75,801
-1,564
| -2% | -$20.1K |
|
|
DRNA
2487
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $988K | ﹤0.01% |
49,026
-87,569
| -64% | -$2.42M |
|
|
FRONU
2488
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $987K | ﹤0.01% |
100,000
| – | – |
|
|
MACQ
2489
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
| $987K | ﹤0.01% |
100,000
-95,888
| -49% | -$938K |
|
2490
Arcturus Therapeutics
ARCT
$178M
| $985K | ﹤0.01% |
20,616
-185
| -0.9% | -$8.29K |
|
2491
US Physical Therapy
USPH
$1.18B
| $984K | ﹤0.01% |
8,894
-236
| -3% | -$26.9K |
|
2492
NBT Bancorp
NBTB
$2.77B
| $983K | ﹤0.01% |
27,185
-1,883
| -6% | -$66.1K |
|
|
MRSN
2493
DELISTED
Mersana Therapeutics
MRSN
| $982K | ﹤0.01% |
4,168
-3,685
| -47% | -$1.08M |
|
2494
FB Financial Corp
FBK
$3.09B
| $976K | ﹤0.01% |
22,766
-593
| -3% | -$23.5K |
|
|
CCXI
2495
DELISTED
ChemoCentryx, Inc.
CCXI
| $976K | ﹤0.01% |
57,063
-72,110
| -56% | -$1.12M |
|
2496
Center Bancorp
CNOB
$1.68B
| $975K | ﹤0.01% |
32,482
-1,789
| -5% | -$49.4K |
|
2497
iShares MSCI Europe Financials ETF
EUFN
$4.27B
| $973K | ﹤0.01% |
+49,570
| New | +$982K |
|
2498
Axcelis
ACLS
$4.2B
| $971K | ﹤0.01% |
20,646
-30,656
| -60% | -$1.33M |
|
2499
Tennant Co
TNC
$1.49B
| $971K | ﹤0.01% |
13,131
-342
| -3% | -$25.7K |
|
2500
TripAdvisor
TRIP
$1.63B
| $971K | ﹤0.01% |
28,679
-85,554
| -75% | -$3.07M |
|
Similar funds
Deutsche Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Deutsche Bank held 4,855 positions worth $211B, up 2.4% from $206B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Deutsche Bank's Q3 2021 filing shows 198 new, 1,525 increased, 2,234 reduced and 397 closed positions. Its largest new stake was AfterNext HealthTech Acquisition Corp Units: 1,163,081 shares worth $11.6M. The largest sale was Alexion Pharmaceuticals, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q3 2021 buy was AfterNext HealthTech Acquisition Corp Units: 1,163,081 shares worth $11.6M.
- Deutsche Bank added most to Amazon in Q3 2021, an estimated $769M increase.
- Deutsche Bank's biggest Q3 2021 reduction was Visa, cutting an estimated $345M.
- Deutsche Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $407M.
- Deutsche Bank's ten largest holdings make up 20% of its $211B portfolio in Q3 2021.
- Deutsche Bank opened 198 new positions and closed 397 in Q3 2021.
- Deutsche Bank's portfolio value rose 2.4% quarter-over-quarter to $211B.
Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.